Filing Details

Accession Number:
0001209191-17-032825
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-16 17:37:28
Reporting Period:
2017-05-16
Filing Date:
2017-05-16
Accepted Time:
2017-05-16 17:37:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827871 Eagle Pharmaceuticals Inc. EGRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1471956 David Pernock Eagle Pharmaceuticals, Inc.
50 Tice Blvd., Suite 315
Woodcliff Lake NJ 07677
Pres. & Chief Comm. Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-16 200 $82.24 711 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct